1. Home
  2. MRBK vs ASMB Comparison

MRBK vs ASMB Comparison

Compare MRBK & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRBK
  • ASMB
  • Stock Information
  • Founded
  • MRBK 2004
  • ASMB 2005
  • Country
  • MRBK United States
  • ASMB United States
  • Employees
  • MRBK N/A
  • ASMB N/A
  • Industry
  • MRBK Major Banks
  • ASMB Biotechnology: Pharmaceutical Preparations
  • Sector
  • MRBK Finance
  • ASMB Health Care
  • Exchange
  • MRBK Nasdaq
  • ASMB Nasdaq
  • Market Cap
  • MRBK 145.8M
  • ASMB 130.2M
  • IPO Year
  • MRBK 2017
  • ASMB 2010
  • Fundamental
  • Price
  • MRBK $13.75
  • ASMB $18.30
  • Analyst Decision
  • MRBK Buy
  • ASMB Strong Buy
  • Analyst Count
  • MRBK 2
  • ASMB 3
  • Target Price
  • MRBK $17.00
  • ASMB $33.00
  • AVG Volume (30 Days)
  • MRBK 106.0K
  • ASMB 40.9K
  • Earning Date
  • MRBK 07-25-2025
  • ASMB 08-07-2025
  • Dividend Yield
  • MRBK 3.67%
  • ASMB N/A
  • EPS Growth
  • MRBK 33.85
  • ASMB N/A
  • EPS
  • MRBK 1.42
  • ASMB N/A
  • Revenue
  • MRBK $101,096,000.00
  • ASMB $32,154,000.00
  • Revenue This Year
  • MRBK $20.44
  • ASMB $0.04
  • Revenue Next Year
  • MRBK $10.56
  • ASMB N/A
  • P/E Ratio
  • MRBK $9.63
  • ASMB N/A
  • Revenue Growth
  • MRBK 8.82
  • ASMB 148.33
  • 52 Week Low
  • MRBK $10.04
  • ASMB $7.75
  • 52 Week High
  • MRBK $17.33
  • ASMB $19.93
  • Technical
  • Relative Strength Index (RSI)
  • MRBK 63.72
  • ASMB 70.46
  • Support Level
  • MRBK $11.16
  • ASMB $17.45
  • Resistance Level
  • MRBK $13.00
  • ASMB $18.92
  • Average True Range (ATR)
  • MRBK 0.59
  • ASMB 0.87
  • MACD
  • MRBK 0.22
  • ASMB -0.05
  • Stochastic Oscillator
  • MRBK 89.62
  • ASMB 79.87

About MRBK Meridian Corporation

Meridian Corp is a bank holding company. Through its banking subsidiary, it operates as a full-service, state-chartered commercial bank providing personal, business lending, and deposit services. It operates in three reportable segments including Bank, Wealth, and Mortgage. The company generates maximum revenue from the Bank segment which consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: